Product Description
Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. It can promote insulin secretion, inhibit glucagon secretion, delay gastric emptying, reduce hunger sensation and food intake. It effectively lowers blood sugar, reduces body weight, improves insulin resistance and protects cardiovascular health.
Indications
- Glycemic control in adults with type 2 diabetes mellitus
- Adjuvant treatment for overweight and obese people to reduce body weight
- Improve blood lipid metabolism and reduce metabolic syndrome risks
- Combined with diet and exercise for long-term metabolic management
Administration
Only for subcutaneous injection Injection site: abdomen, thigh or upper arm Not for intravenous or intramuscular injection Daily fixed time injection, start with low dose and gradually increase
Product Features
- Stable blood sugar lowering effect, low hypoglycemia risk
- Significant appetite suppression and weight loss effect
- Improve islet function and delay disease progression
- Easy-to-use prefilled injection pen, convenient for home use
- Good safety and high clinical recognition
Storage
Store at 2℃~8℃ refrigerated, avoid freezing and strong light Do not place in high temperature environment
Warnings
- Strict prescription drug, use under doctor guidance
- Contraindicated in patients with history of medullary thyroid cancer
- Forbidden for hypersensitivity to liraglutide and ingredients
- Common side effects: mild nausea, bloating, diarrhea, mostly self-relieved
- Not applicable for type 1 diabetes and diabetic ketoacidosis
- Pregnant women, lactating women and minors are not recommended
- Keep away from children
